What a pharmacy may be able to mix
Wolverine Legal Status and the Unclear Pharmacy Answer
Neither BPC-157 nor TB-500 is approved. Both left the federal safety-warning group after their requests were pulled, but the agency hasn't said that pharmacies may now mix them.
What Wolverine legal status means for a pharmacy today
A custom-shot bill can be large, so before you pay in 2026, you'll want to know that federal records still don't give pharmacies a clear yes on mixing these substances. That answer isn't settled.
A federal group met on July 23-24, 2026 to discuss whether the ingredients belonged on an allowed list [14]. Agency staff proposed against listing both, and no vote record has been published.
The April 22, 2026 page says sponsors pulled their earlier requests for BPC-157 and TB-500. That took both out of Category 2, the group for substances with safety worries, but didn't approve either drug [12].
Officials first put both substances in Category 2 on September 29, 2023. The old warning and the pulled requests explain the concern, yet neither one by itself settles whether a pharmacy may prepare them.
The July 2026 meeting was a review, not an approval [14]. For you, the plain answer is that pharmacy mixing remains unclear.
What Category 2 means in federal pharmacy law
Federal law has one rule for a state pharmacy filling your own prescription. A second rule covers larger batches made by special drug-making sites [13].
The first rule is for medicine mixed after a doctor writes for one patient. The other rule covers sites that make stock for hospitals or clinics.
Officials sort requested ingredients while they review them. Category 1 means an ingredient is still under review and may be mixed during that work [13].
Category 2 means officials see a serious safety risk [12]. A pharmacy can't treat a Category 2 ingredient as routine mixing stock.
On January 7, 2025, the agency stopped adding new requests to those groups [13]. Earlier Category 2 entries stayed restricted, and neither BPC-157 nor TB-500 became an approved drug [13].
The Category 2 warning isn't the same as drug approval. It tells you why a careful pharmacy asks about the federal record.
If a clinic offers this mix, I'd ask which federal rule permits the pharmacy to make it. A careful clinic will answer that before taking your money.
What the federal record says about each substance
Neither substance has a special legal pass. Federal records placed BPC-157 and TB-500 on the July 23-24, 2026 meeting list [14].
A page dated April 22, 2026 says the sponsors pulled their requests [12]. That removed both from Category 2 but didn't approve them.
The same record names two chemical forms of BPC-157 [12]. You don't need those lab names to see that both refer to BPC-157, the same unapproved substance.
For TB-500, the record says it is made from a brief piece of Thymosin Beta-4, a larger repair protein [12]. Officials had put both ingredients on the warning list on September 29, 2023 because of immune reactions and dirty contents.
The record names that parent protein as Thymosin Beta-4 and names the small part as TB-500. It also lists BPC-157 beside TB-500, so both ingredients remain part of the federal review.
The July 2026 meeting was only a review step [14]. Staff proposed against adding both to the allowed list, and no public vote record gives your pharmacy a final answer.
What a pharmacy needs before making a custom drug
A custom-mixed medicine begins with a real visit and a prescription written for you [13]. A licensed state pharmacy or a registered drug-making site then prepares it [13].
A video visit may be how you speak with the doctor. It doesn't change which substances a pharmacy can prepare [13].
The ingredient must be allowed by federal law. It may be in an official drug recipe book, already part of an approved drug, or on a federal list of ingredients that pharmacies may use.
A safety warning can block routine mixing while it stands [13]. BPC-157 and TB-500 aren't in the warning group now, but the agency hasn't said their pulled requests make mixing lawful.
A doctor's order by itself doesn't answer that question. Ask the clinic to name the rule its pharmacy uses before you pay.
What the sports ban changes for an athlete
Sports rules ban both substances even though pharmacy law is unsettled. The World Anti-Doping Agency places BPC-157 in its group for drugs that haven't been approved, and it also bans TB-500 and Thymosin Beta-4, its full parent protein.
An athlete can face a penalty for using the blend during or outside a contest. You face that sports ban apart from the rules a pharmacy follows.
Sport and clinical access
Two rulebooks, kept separate
For Wolverine (research blend), the boundary is twofold: WADA status governs eligibility in tested sport, while prescription-only peptide care is accessed through a licensed clinician-led route such as Promise Peptides (mypromise.com); neither category changes what the component literature can establish about the pairing.
Can a prescription make Wolverine legal?
You can't make an unapproved substance into an approved drug with a prescription. Neither BPC-157 nor TB-500 is approved for any illness, and the blend isn't approved [12][13].
The April 22, 2026 page shows that both substances are now outside Category 2 [12]. Even so, the agency hasn't said that a pharmacy may mix either one.
Athletes also can't use them under sports rules. A lawful custom drug needs a doctor's review, a valid prescription, and an allowed ingredient [13].
Is BPC-157 approved by the FDA?
No. Officials put BPC-157 in Category 2 on September 29, 2023 [12], then the April 22, 2026 page said its sponsor had pulled the BPC-157 request.
That change took BPC-157 off the warning list, but FDA still lists its safety concerns, and it didn't approve the drug. The July 23-24, 2026 meeting considered whether pharmacies could use it [14].
Agency staff proposed against adding it to the allowed list. You won't find a published vote record with a later approval decision.
Can a custom pharmacy mix Wolverine now?
The federal pages leave the answer unsettled. Both substances and the blend remain unapproved [12][13].
BPC-157 and TB-500 entered Category 2 on September 29, 2023 [12]. The April 22, 2026 page no longer lists them because their sponsors pulled the requests.
A federal group discussed both at its July 23-24, 2026 meeting [14]. Staff proposed against putting them on the allowed list, and no vote record has been published.
Neither substance is in Category 2 today. That fact isn't approval, and it isn't clear permission for your pharmacy to mix the blend.